Victrex plc (VCT) Receives Average Recommendation of “Hold” from Brokerages
Victrex plc (LON:VCT) has been assigned a consensus rating of “Hold” from the eleven brokerages that are presently covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is GBX 2,276.80 ($30.64).
A number of brokerages recently issued reports on VCT. Liberum Capital increased their price objective on Victrex from GBX 2,440 ($32.84) to GBX 2,770 ($37.28) and gave the stock a “buy” rating in a report on Monday. Berenberg Bank reissued a “buy” rating and issued a GBX 2,600 ($34.99) price objective on shares of Victrex in a report on Tuesday, December 5th. J P Morgan Chase & Co increased their price objective on Victrex from GBX 2,150 ($28.94) to GBX 2,250 ($30.28) and gave the stock a “neutral” rating in a report on Wednesday, December 6th. Barclays decreased their price objective on Victrex from GBX 2,350 ($31.63) to GBX 2,270 ($30.55) and set an “equal weight” rating for the company in a report on Tuesday, November 28th. Finally, Peel Hunt lowered Victrex to a “hold” rating and set a GBX 2,300 ($30.96) price objective for the company. in a report on Tuesday, October 31st.
Victrex (LON VCT) opened at GBX 2,573.84 ($34.64) on Thursday. Victrex has a fifty-two week low of GBX 1,815 ($24.43) and a fifty-two week high of GBX 2,607 ($35.09).
Victrex Company Profile
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.